| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2143 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1578 | 2018 |
| Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems GL Daikos, S Tsaousi, LS Tzouvelekis, I Anyfantis, M Psichogiou, ... Antimicrobial agents and chemotherapy 58 (4), 2322-2328, 2014 | 720 | 2014 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 680* | 2014 |
| PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 64 (4), 800-806, 2016 | 474 | 2016 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 385 | 2022 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study EUHCV COLLABORATORS Lancet Gastroenterol Hepatol 2, 161-76, 0 | 326* | |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study EUHCV COLLABORATORS Lancet Gastroenterol Hepatol 2, 325-36, 2017 | 318 | 2017 |
| The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B GV Papatheodoridis, R Idilman, GN Dalekos, M Buti, H Chi, ... Hepatology 66 (5), 1444-1453, 2017 | 309 | 2017 |
| The effectiveness of a 9-month regimen of isoniazid alone versus 3-and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children … NP Spyridis, PG Spyridis, A Gelesme, V Sypsa, M Valianatou, F Metsou, ... Clinical Infectious Diseases 45 (6), 715-722, 2007 | 298 | 2007 |
| Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis GK Nikolopoulo, D Paraskevis, E Hatzitheodorou, Z Moschidis, V Sypsa, ... Clinical Infectious Diseases 48 (12), 1763-1771, 2009 | 288 | 2009 |
| Short-term associations between fine and coarse particulate matter and hospitalizations in Southern Europe: results from the MED-PARTICLES project M Stafoggia Environ Health Perspect 121, 1026-33, 2013 | 255 | 2013 |
| Associations between fine and coarse particles and mortality in Mediterranean cities: results from the MED-PARTICLES project E Samoli Environ Health Perspect, 2013 | 252 | 2013 |
| aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ... Journal of hepatology 73 (6), 1368-1378, 2020 | 233 | 2020 |
| Desert Dust Outbreaks in Southern Europe: Contribution to Daily PM(1)(0) Concentrations and Short-Term Associations with Mortality and Hospital Admissions M Stafoggia Environ Health Perspect, 2016 | 201 | 2016 |
| Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir GV Papatheodoridis, GN Dalekos, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 62 (2), 363-370, 2015 | 185 | 2015 |
| A survey of bloodborne viruses and associated risk behaviours in Greek prisons M Malliori, V Sypsa, M Psichogiou, G Touloumi, A Skoutelis, ... Addiction 93 (2), 243-251, 1998 | 164 | 1998 |
| Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis C Arum, H Fraser, AA Artenie, S Bivegete, A Trickey, M Alary, ... The Lancet public health 6 (5), e309-e323, 2021 | 146 | 2021 |
| Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey V Sypsa, T Livanios, M Psichogiou, M Malliori, S Tsiodras, ... Eurosurveillance 14 (49), 2009 | 146 | 2009 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2 V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ... Journal of viral hepatitis 22, 6-25, 2015 | 144 | 2015 |
Angelos HatzakisProfessor of Epidemiology and Preventive Medicine-National and Kapodistrian University of Athens在 med.uoa.gr 的电子邮件经过验证
